Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Oncology (Williston Park, N.Y.)
|
February 11, 2004
Introduction. Single-agent or combination chemotherapy in metastatic breast cancer
Andrew Seidman
Seminars in Oncology
|
December 6, 2006
Adjuvant therapy with aromatase inhibitors for postmenopausal women with early breast cancer: evidence and ongoing controversy
Jennifer Wheler, Melissa Johnson, Andrew Seidman
The Oncologist
|
January 16, 2015
In reply
Binghe Xu, Andrew Seidman, Stephen Chan
Clinical Breast Cancer
|
September 1, 2010
Adjuvant taxanes: more to the story
Devika Gajria, Andrew Seidman, Chau Dang
Oncology (Williston Park, N.Y.)
|
November 19, 2002
HER2 testing and correlation with efficacy of trastuzumab therapy
Monica Fornier, Mauro Risio, Catherine Van Poznak, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 22, 2023
Response to Kochan et al., 2023
Barbara E Ehrlich, Linda Vahdat, Arthur P DeCillis, et al.
Clinical Breast Cancer
|
October 28, 2004
Effect of cardiac dysfunction on treatment outcomes in women receiving trastuzumab for HER2-overexpressing metastatic breast cancer
Debu Tripathy, Andrew Seidman, Deborah Keefe, et al.
The Breast Journal
|
November 24, 2012
Hepatic arterial infusion and systemic chemotherapy for breast cancer liver metastases
Celina Ang, Komal Jhaveri, Dina Patel, et al.
Journal of Psychiatric Research
|
March 30, 2023
History of major depressive disorder is associated with differences in implicit learning of emotional faces
Antonija Kolobaric, Akiko Mizuno, Xiao Yang, et al.
Breast Cancer Research and Treatment
|
January 20, 2018
Living with chronic pain: perceptions of breast cancer survivors
Ting Bao, Andrew Seidman, Qing Li, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Oncology (Williston Park, N.Y.)
|
February 11, 2004
Introduction. Single-agent or combination chemotherapy in metastatic breast cancer
Andrew Seidman
Seminars in Oncology
|
December 6, 2006
Adjuvant therapy with aromatase inhibitors for postmenopausal women with early breast cancer: evidence and ongoing controversy
Jennifer Wheler, Melissa Johnson, Andrew Seidman
The Oncologist
|
January 16, 2015
In reply
Binghe Xu, Andrew Seidman, Stephen Chan
Clinical Breast Cancer
|
September 1, 2010
Adjuvant taxanes: more to the story
Devika Gajria, Andrew Seidman, Chau Dang
Oncology (Williston Park, N.Y.)
|
November 19, 2002
HER2 testing and correlation with efficacy of trastuzumab therapy
Monica Fornier, Mauro Risio, Catherine Van Poznak, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 22, 2023
Response to Kochan et al., 2023
Barbara E Ehrlich, Linda Vahdat, Arthur P DeCillis, et al.
Clinical Breast Cancer
|
October 28, 2004
Effect of cardiac dysfunction on treatment outcomes in women receiving trastuzumab for HER2-overexpressing metastatic breast cancer
Debu Tripathy, Andrew Seidman, Deborah Keefe, et al.
The Breast Journal
|
November 24, 2012
Hepatic arterial infusion and systemic chemotherapy for breast cancer liver metastases
Celina Ang, Komal Jhaveri, Dina Patel, et al.
Journal of Psychiatric Research
|
March 30, 2023
History of major depressive disorder is associated with differences in implicit learning of emotional faces
Antonija Kolobaric, Akiko Mizuno, Xiao Yang, et al.
Breast Cancer Research and Treatment
|
January 20, 2018
Living with chronic pain: perceptions of breast cancer survivors
Ting Bao, Andrew Seidman, Qing Li, et al.
Page
of 3